Sanofi S.A. is a French multinational pharmaceutical and healthcare company which was established in 1973. Headquartered in Paris, its core businesses span across pharmaceuticals, vaccines and consumer healthcare.

Investing in pharmaceutical stocks often means betting on innovation and consistent cash flow. With a strong market presence and a robust portfolio, Sanofi is no exception. But is it currently undervalued or an opportunity waiting to be seized? In this detailed analysis, we’ll dissect Sanofi’s financial statements and ratios to determine whether this large-cap stock should be on your radar.